Apiam Animal Health Limited (ASX:AHX) Investor Update
Apiam Animal Health Limited (ASX:AHX) has expanded in Western Australia, via the acquisition of Harradine & Associates announced last week.
Companies in the News
Biotech
VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into an R&D Loan Facility Agreement (Loan Facility) with Fundsquire Pty Ltd.
Apiam Animal Health Limited (ASX:AHX) Acquisition of Harradine & Associates Veterinary Business
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the acquisition of Harradine & Associates, a large veterinary business located in the southwest region of Western Australia.
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH Phase II Clinical Study
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced dosing of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease.
Apiam Animal Health Limited (ASX:AHX) Announce Board Renewal and Key AGM Dates
Apiam Animal Health Limited (ASX:AHX) is pleased to announce the appointment of Ms Evonne Collier as a Non-Executive Director to the Company's Board of Directors, with effect from 1 October.
VGI Health Technology Limited (NSX:VTL) Receives Ethics Approval for US Clinical Study
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received ethics approval to proceed with a US pharmacokinetics and exercise clinical study.
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has made significant progress in its Phase II clinical study in Non-Alcoholic Fatty Liver Disease (NAFLD)/Non-Alcoholic SteatoHepatitis (NASH).
◂Previous Page
Biotech Next Page▸
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- Deep Yellow Limited (ASX:DYL) Tumas Project Development Update - Positive Progress
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Test Detects Muscle Damage in Thoroughbred Racehorses
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
Social Media
